Skip to Content

Clinical Trials Search Results

Showing 1-2 of 2

Sorted By:

  • MCC13311

    Choosing Neoadjuvant Chemotherapy versus Hormonal Therapy for Breast Cancer Based on Gene Expression Profile

  • NSABP B-52

    A Randomized Phase III Trial Evaluating Pathologic Complete Response Rates in Patients with Hormone Receptor-Positive, HER2-Positive, Large Operable and Locally Advanced Breast Cancer Treated with Neoadjuvant Therapy of Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab (TCHP) With or Without Estrogen Deprivation

Showing trials 1-2 of 2

Also in this Section